PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Precision targeting of the centromedian nucleus in drug-resistant epilepsy highlighted in brain network disorders

Advanced imaging and neurophysiological techniques enhance the precision of deep brain stimulation targeting the centromedian nucleus in drug-resistant epilepsy

2025-09-16
(Press-News.org)

It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications. These patients, having drug-resistant epilepsy, have limited treatment options beyond surgery to control their seizures. Even surgical interventions become difficult in many of these patients due to challenges in pinpointing the anatomical source of their seizures, such as the seizures originating from multiple regions of the brain. Deep brain stimulation (DBS), a treatment that involves an implanted device that delivers an electrical current directly to areas of the brain, has emerged as a promising alternative, offering partial seizure control for patients who are not eligible for resective surgery.

In DBS, electrical impulses are delivered to parts of the brain, which are the epicenter of seizures, using precisely implanted electrodes. Electrical stimulation of the anterior nucleus of the thalamus is already approved for epilepsy in Europe and Canada. The attention is now turning towards another thalamic target, the centromedian nucleus (CM). Scientists estimate that targeting the CM, with its extensive cortical and subcortical connections, could be an effective avenue for treating general and frontal lobe seizures, including those associated with conditions like Lennox–Gastaut syndrome.

However, targeting the CM is not easy. It is small in size, located deep, and is near other thalamic nuclei, making it hard to pinpoint using standard imaging techniques. This raises the risk of faulty electrode placement, leading to poor surgical outcomes. As such, these limitations hinder CM-DBS from being widely adopted as a treatment.

In a recent review article, a team of researchers from the University Hospital La Princesa, Madrid, led by Dr. Cristina Virgina Torres Díaz, in collaboration with the University Medical Center of the Johannes Gutenberg University Mainz, reviewed advanced approaches for improving the accuracy of targeting the CM during DBS. These methods include high-resolution magnetic resonance imaging (MRI) techniques, intraoperative microelectrode recordings (MER), and diffusion tensor imaging (DTI) tractography. Together, these tools offer a multimodal approach towards seizure control and better outcomes. The article was published in Volume 1, Issue 2 of the journal Brain Network Disorders and made available online on March 9, 2025.

“Our primary goal was to reduce targeting errors and expand the clinical viability of CM-DBS,” says Dr. Torres Díaz, corresponding author of the study. “By integrating advanced imaging and neurophysiology, we can more confidently localize the CM, especially in patients with complex anatomy or structural abnormalities.”

The paper starts by discussing an MRI sequence known as magnetization-prepared 2 rapid acquisition gradient echo (MP2RAGE), used for high-resolution brain imaging. MP2RAGE enhances the contrast between the CM and surrounding thalamic structures, facilitating clearer anatomical differentiation. Together with 3D brain atlases and image gradient analysis, MP2RAGE allows more accurate visualization of the CM. Other techniques, such as quantitative susceptibility mapping (QSM) and edge-enhancing gradient echo with multi-image co-registration and averaging (EDGE-MICRA), have also additional potential for improving CM delineation.

Next, the authors examined the role of intraoperative MER in improving DBS localization. In MER, microelectrodes are used to record electrical activity from deep brain structures and help differentiate between neighboring tissues based on neural firing patterns. MER data from some studies show that the CM exhibits distinctive ‘tonic activity’ and ‘lower spike rates’ compared to adjacent nuclei (e.g., the ventral lateral nucleus). This neurophysiological signature can help guide electrode placement during DBS surgery.

The review also explored the application of DTI tractography, which can help identify relevant brain pathways and improve stimulation by targeting specific circuits. Studies that used tractography showed that the optimal stimulation areas were closely linked to fiber tracts connecting the CM to the brainstem, cerebellum, sensorimotor cortex, and supplementary motor area. Patients whose electrodes were optimally aligned with these pathways experienced significant reductions (50% or more) in seizure frequency.

“Through the review of our own patient series, we found that patients who responded most favorably to CM-DBS had strong structural and functional links between the stimulation site and specific brain networks involved in motor regulation and arousal,” Dr. Torres Díaz explained. “This highlights the importance of targeting not just a nucleus, but the circuits it controls.”

This review serves as a comprehensive roadmap for implementing CM-DBS in patients with drug-resistant epilepsy. By combining imaging modalities, electrophysiological mapping, and connectivity analysis, a team of surgeons can accurately implant electrodes and even accommodate for differences in brain structure and seizure network. This tailored approach has the potential to improve outcomes while minimizing surgical risks.

“As diagnostic tools advance and improve our understanding of brain networks, CM-DBS could offer life-changing results for patients once deemed untreatable,” concludes Dr. Torres Díaz. “Precision targeting is not just a technical achievement; it is a path to renewed hope for people with the most challenging forms of epilepsy.”

 

***

 

Reference
DOI: 10.1016/j.bnd.2024.11.002

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Better understanding of bitter taste receptors: An AlphaFold3-based structure study

2025-09-16
Receptor proteins, expressed on the cell surface or within the cell, bind to different signaling molecules, known as ligands, initiating cellular responses. Taste receptors, expressed in oral tissues, interact with tastants, the molecules responsible for the sensation of taste. Bitter taste receptors (T2Rs) are responsible for the sensation of bitter taste. However, apart from oral tissue, these receptors are also expressed in the neuropod cells of the gastrointestinal tract, which are responsible for transmitting signals from the gut to the brain. Thus, T2Rs might play a crucial role in maintaining the gut-brain axis. 25 types of human T2Rs have been identified to date. However, due ...

Artificial intelligence spots hidden signs of depression in students’ facial expressions

2025-09-16
Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or subthreshold depression (StD) (a mild state of depressive symptoms that does not meet the criteria for diagnosis but is a risk factor for developing depression) is associated with changes in facial expressions remains unknown. In light of this, Associate Professor Eriko Sugimori and doctoral student Mayu Yamaguchi ...

UT San Antonio astronomy professor awarded for advancements in planetary science

2025-09-16
Xinting Yu, assistant professor in the Department of Physics and Astronomy at The University of Texas at San Antonio, is one of two recipients of the 2025 Harold C. Urey Prize. The national award from the American Astronomical Society’s Division for Planetary Sciences recognizes early-career scientists shaping the future of space research. Yu was honored for her research in planetary and exoplanetary science — the study of planets in our solar system and beyond. Her work focuses on how planetary surfaces and atmospheres interact and evolve. By combining ...

‘Internal alarm system’ harnesses immune system against cancer

2025-09-16
Scientists have developed a smarter way to activate the immune system against cancer, potentially making treatments safer and more precise. The research focuses on a powerful pathway inside our cells known as STING. When triggered, STING acts like an internal alarm system, sending out signals that summon the body’s immune system to attack. Drugs that activate this pathway have shown promise in cancer therapy, but until now, they faced a major problem: if switched on in healthy tissues, they can cause harmful and sometimes dangerous side effects. To solve this problem, researchers from the University of Cambridge designed a two-part ‘prodrug’ ...

Stem cell transplant for stroke leads to brain cell growth and functional recovery in mice

2025-09-16
When someone has a stroke — a leading worldwide cause of death and disability — time is of the essence. Almost nine out of 10 cases are ischemic strokes, caused by restricted blood flow in the brain, and the current gold-standard treatment that breaks up blood clots must be delivered within four and a half hours of symptoms appearing.  Researchers are on the hunt for ways to extend that ticking clock and enable better stroke recovery. One promising prospect is an experimental stem cell therapy to help repair damaged brain tissue, co-developed by scientists at the Keck School of Medicine of USC, the University of ...

Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines

2025-09-16
UNDER EMBARGO Tuesday, September 16, 2025, 05:00 a.m. ET, CLEVELAND: A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.   Patients who had weight-loss surgery (also known as bariatric or metabolic surgery) lost more weight, achieved better blood sugar control, and relied less on diabetes and heart medications over 10 years. The research is published ...

Revised diagnostic criteria for vascular cognitive impairment and dementia—The VasCog-2-WSO criteria

2025-09-16
About The Study: The International Society for Vascular Behavioural and Cognitive Disorders (VasCog)-2- World Stroke Organization (WSO) criteria update the VasCog criteria for the diagnosis of vascular cognitive impairment and dementia (VCID), providing operationalization and additional guidance on potential neuroimaging and fluid biomarkers. VasCog-2-WSO should provide an international standard for VCID diagnosis, facilitating diagnostic consistency among clinicians and researchers. Corresponding Authors: To contact the corresponding authors, email ...

The ATREIDES program in search of lost exo-Neptunes

2025-09-16
An international team led by the University of Geneva (UNIGE), including scientists from the National Centre of Competence in Research PlanetS, the University of Warwick, and the Canary Islands Institute of Astrophysics, has launched an ambitious program to map exoplanets located around the Neptunian Desert. The goal: to better understand the formation and evolution of planetary systems. This collaboration, known as ATREIDES, has delivered its first results with the observation of the TOI-421 planetary system. Analysis of this system reveals a surprisingly inclined orbital architecture, offering new insights ...

Ancient crop discovered in the Canary Islands thanks to archaeological DNA

2025-09-16
The lentils now grown in the Canary Islands have a history that stretches back almost 2,000 years on the site. This is shown in the very first genetic study of archaeological lentils, carried out by researchers at Linköping University and the University of Las Palmas de Gran Canaria in Spain. Since these lentils have been adapted for cultivation in hot and dry climates for a very long time, they may become valuable for plant breeding in the light of ongoing climate change. Over a thousand years ago, the indigenous people of the island of Gran Canaria used long-term storage to preserve their harvest. They dug out grain silos ...

Placental research may transform our understanding of autism and human brain evolution

2025-09-16
CAMBRIDGE, England, UNITED KINGDOM, 9 September 2025 -- In a Genomic Press Interview published today in Brain Medicine, Dr. Alex Tsompanidis highlights an exciting new idea that positions the placenta at the center of human neurodevelopment and evolution, challenging conventional wisdom about the origins of autism and human cognition. The interview, part of Genomic Press's Innovators & Ideas series, captures a pivotal moment in neuroscience as researchers worldwide recognize pregnancy biology as fundamental to understanding brain diversity across all human populations. Revolutionary Framework Reshapes Global Understanding Dr. Tsompanidis, honored as one of Spectrum magazine's ...

LAST 30 PRESS RELEASES:

Outstanding postdoctoral researchers honored with 2025 Blavatnik Regional Awards for Young Scientists

Fly through Gaia’s 3D map of stellar nurseries

Precision targeting of the centromedian nucleus in drug-resistant epilepsy highlighted in brain network disorders

Better understanding of bitter taste receptors: An AlphaFold3-based structure study

Artificial intelligence spots hidden signs of depression in students’ facial expressions

UT San Antonio astronomy professor awarded for advancements in planetary science

‘Internal alarm system’ harnesses immune system against cancer

Stem cell transplant for stroke leads to brain cell growth and functional recovery in mice

Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines

Revised diagnostic criteria for vascular cognitive impairment and dementia—The VasCog-2-WSO criteria

The ATREIDES program in search of lost exo-Neptunes

Ancient crop discovered in the Canary Islands thanks to archaeological DNA

Placental research may transform our understanding of autism and human brain evolution

Mapping the Universe, faster and with the same accuracy

Study isolates population aging as primary driver of musculoskeletal disorders

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

[Press-News.org] Precision targeting of the centromedian nucleus in drug-resistant epilepsy highlighted in brain network disorders
Advanced imaging and neurophysiological techniques enhance the precision of deep brain stimulation targeting the centromedian nucleus in drug-resistant epilepsy